ARCHIVES

Advocates Oppose Proposals to Market Drugs After Phase I.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Breast Treatment Component Will Be Planned for WHI

June 21, 1991

NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants

November 30, 1990

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

August 31, 2012

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

December 19, 2008

Palmetto Establishes Coverage For Thyroid Genomic Test

January 27, 2012

In Brief: Masnyk Named DCBD Deputy Director Maizel to Head NCI’s “Supercomputer” Development

November 2, 1984